Italy: The Competition Authority fines anti-competitive Practices aimed at delaying Market Entry for generic Medicines* On 11 January 2012, the Italian Competition Authority (ICA) sanctioned the multinational pharmaceutical group Pfizer (Pfizer) for a violation of Article 102 TFEU and imposed on it a fine amounting to € 10 677 706. In October 2010, following a complaint filed by the generic company Ratiopharm Italia S.r.l., the ICA opened proceedings against Pfizer (in particular against Pfizer Inc. and its subsidiaries Pfizer Italia S.r.l. and Pfizer Health A.B.) for an alleged infringement of Article 102 TFEU on the Italian market for
The Italian Competition Authority fines anti-competitive practices aimed at delaying market entry for generic medicines (Pfizer)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.